Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors

Bioorg Med Chem. 2013 Nov 15;21(22):7216-21. doi: 10.1016/j.bmc.2013.08.032. Epub 2013 Sep 11.

Abstract

A series of phosphonate analogues related to perindopril and ramipril were prepared and tested to estimate their ability to inhibit angiotensin converting enzyme. These new synthesized compounds were active ACE inhibitors with a promising activity.

Keywords: Angiotensin converting enzyme; Hypertension; Inhibitors; Phosphonate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / chemical synthesis
  • Angiotensin-Converting Enzyme Inhibitors / chemistry*
  • Angiotensin-Converting Enzyme Inhibitors / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Binding Sites
  • Catalytic Domain
  • Enzyme Activation / drug effects
  • Humans
  • Molecular Docking Simulation
  • Organophosphonates / chemistry*
  • Peptidyl-Dipeptidase A / chemistry
  • Peptidyl-Dipeptidase A / metabolism
  • Perindopril / analogs & derivatives*
  • Perindopril / chemical synthesis
  • Perindopril / metabolism
  • Perindopril / pharmacology*
  • Protein Binding
  • Ramipril / analogs & derivatives*
  • Ramipril / chemical synthesis
  • Ramipril / metabolism
  • Ramipril / pharmacology*
  • Stereoisomerism

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Organophosphonates
  • ACE protein, human
  • Peptidyl-Dipeptidase A
  • Ramipril
  • Perindopril